2470 DANIELLS BRIDGE RD STE 231
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Athens, Georgia.
Need a clinic that prescribes Ozempic, Wegovy, or Mounjaro? Our directory lists 6 verified providers serving Athens, Georgia (128,691 residents · 35.4% adult obesity).
Each clinic below offers GLP-1 weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound. Compare ratings, services, and pricing — then book directly or via our partner directory at GLP1Maps.com.
2470 DANIELLS BRIDGE RD STE 231
Metabolic medicine provider specializing in medical weight management, bariatric care, and GLP-1 treatment in Athens, Georgia.
2470 Daniels Bridge Rd Ste 221, Athens, GA 30606
Dr. Jeremy Anthony, MD is a endocrinology specialist in Athens, Georgia.
Po Box 48089, Athens, GA 30604
Dr. Lucia Cotten, MD is a endocrinology specialist in Athens, Georgia.
700 Sunset Dr Ste 601, Athens, GA 30606
Dr. Kent Lyon, MD is a endocrinology specialist in Athens, Georgia.
218 Thornhill Dr, Athens, GA 30607
Dr. Malek Mushref, M.D. is a endocrinology specialist in Athens, Georgia.
2470 Daniells Bridge Rd Ste 231, Athens, GA 30606
Dr. Mohana Laasya Cherukuri, MD is a obesity medicine specialist in Athens, Georgia.
Full directory of verified providers on GLP1Maps.com
Get an AI Receptionist that books patients 24/7 — from GLP1Receptionist.com
Read Shep's Method — patient guide to GLP-1 success at ShepsMethod.com
Independent network of GLP-1 resources serving Athens and patients across the U.S.
Choosing the right GLP-1 provider in Athens matters. Look for clinics that offer:
GLP-1 receptor agonists work by mimicking a hormone that regulates appetite and blood sugar. The main options:
Georgia Medicaid covers GLP-1 for diabetes only.
For state regulation info, see the Georgia Medical Board.
Our directory lists 6 verified GLP-1 clinics in the Athens area, with rankings based on patient reviews, services offered, and verified provider status.
Georgia Medicaid covers GLP-1 for diabetes only.
Following the FDA's April 2026 503B ruling, compounded semaglutide and tirzepatide are no longer available from most U.S. pharmacies. Most clinics now prescribe FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound.